Literature DB >> 26921192

Biochemical and in silico Characterization of Recombinant L-Lactate Dehydrogenase of Theileria annulata.

Belma Nural1, Aysegul Erdemir2, Ozal Mutlu3, Sinem Yakarsonmez2, Ozkan Danis4, Murat Topuzogullari2, Dilek Turgut-Balik5.   

Abstract

Theileria annulata is a parasite that causes theileriosis in cattle. Reports about drug resistance made essential to develop new drug. LDH of Theileria schizonts is the vital enzyme for its anaerobic metabolism. TaLDH gene was first cloned into pGEM-T cloning vector with two introns in our previous study. Here we report cloning of TaLDH without introns into pLATE 31 vector in E. coli BL21(DE3). Protein was in an inactive form. Two mutations were fixed to express the active protein. Protein was purified by affinity chromatography and evaluated by SDS-PAGE and size exclusion chromatography. Optimum pH of enzyme was performed in pH 7.5, and enzyme was stabilized at 20-40 °C. Enzyme kinetics of recombinant TaLDH were found to be in the direction of pyruvate to lactate K m 0.1324 and K i 4.295 mM, k cat, 44.55/s and k cat /K m, 3.3693 × 10(5)/M/s. 3D structure of TaLDH was predicted, and possible drug binding sites were determined by homology modelling.

Entities:  

Keywords:  Homology modelling; LDH; Substrate inhibition; Theileria annulata; Thermostability

Mesh:

Substances:

Year:  2016        PMID: 26921192     DOI: 10.1007/s12033-016-9924-3

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  38 in total

1.  Protein secondary structure prediction based on position-specific scoring matrices.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

2.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

3.  Protein engineering tests of a homology model of Plasmodium falciparum lactate dehydrogenase.

Authors:  C O Hewitt; R B Sessions; T R Dafforn; J J Holbrook
Journal:  Protein Eng       Date:  1997-01

4.  Treatment of Theileria annulata infection in calves with parvaquone.

Authors:  N McHardy; D W Morgan
Journal:  Res Vet Sci       Date:  1985-07       Impact factor: 2.534

Review 5.  NAD-binding domains of dehydrogenases.

Authors:  A M Lesk
Journal:  Curr Opin Struct Biol       Date:  1995-12       Impact factor: 6.809

6.  Enzymes of glucose and glycerol catabolism in in vitro-propagated Theileria parva schizonts.

Authors:  T N Kiama; J K Kiaira; V N Konji; A J Musoke
Journal:  Vet J       Date:  1999-11       Impact factor: 2.688

7.  Removal of substrate inhibition in a lactate dehydrogenase from human muscle by a single residue change.

Authors:  C M Eszes; R B Sessions; A R Clarke; K M Moreton; J J Holbrook
Journal:  FEBS Lett       Date:  1996-12-16       Impact factor: 4.124

8.  Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity.

Authors:  Angus Cameron; Jon Read; Rebecca Tranter; Victoria J Winter; Richard B Sessions; R Leo Brady; Livia Vivas; Anna Easton; Howard Kendrick; Simon L Croft; David Barros; Jose Luis Lavandera; José Julio Martin; Felix Risco; Silvestre García-Ochoa; Fracisco Javier Gamo; Laura Sanz; Luisa Leon; Jose R Ruiz; Raquel Gabarró; Araceli Mallo; Federico Gómez de las Heras
Journal:  J Biol Chem       Date:  2004-04-26       Impact factor: 5.157

9.  Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use.

Authors:  Kathryn L Kavanagh; Robert A Elling; David K Wilson
Journal:  Biochemistry       Date:  2004-02-03       Impact factor: 3.162

10.  Proteomic analysis of the Theileria annulata schizont.

Authors:  M Witschi; D Xia; S Sanderson; M Baumgartner; J M Wastling; D A E Dobbelaere
Journal:  Int J Parasitol       Date:  2012-11-23       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.